Altre lingue Finch Therapeutics Group, Inc.

Azioni

FNCH

US31773D2009

Tempo differito Nasdaq Altri mercati azionari 17:36:29 01/05/2024			Variaz. 5gg	Var. 1 gen.
2,28 ^USD	+1,79%		-0,87%	-36,84%

25/03	Finch Therapeutics Group, Inc. riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI
12/03	I principali ribassisti del pre-mercato	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Finch Therapeutics Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	25/03
Top Premarket Decliners	12/03
North American Morning Briefing : Stocks Seen -2-	15/11
Finch Therapeutics Group, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	08/11
Acurx Pharmaceuticals Share Price And Volume Are Surging Ahead Of Phase 2b Trial Data Release ($ACXP)	27/10/23
North American Morning Briefing : Stock Futures -2-	16/08/23
Finch Therapeutics Group, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23
Finch Therapeutics Group, Inc. Announces Resignation of Nicholas Haft as Member of Board	23/06/23
Finch Therapeutics Group, Inc.(NasdaqGS:FNCH) dropped from Russell Microcap Index	23/06/23
Finch Therapeutics Group, Inc.(NasdaqGS:FNCH) dropped from Russell Microcap Value Index	23/06/23
Finch Therapeutics Group, Inc.(NasdaqGS:FNCH) dropped from Russell 3000E Value Index	23/06/23
Finch Therapeutics Group, Inc.(NasdaqGS:FNCH) dropped from Russell 3000E Index	23/06/23
Top Premarket Decliners	13/06/23
Finch Therapeutics Group Slumps Almost 15% in Premarket Tuesday	13/06/23
FINCH THERAPEUTICS GROUP, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	09/06/23
Finch Therapeutics Group to Implement 1-for-30 Reverse Stock Split	09/06/23
Finch Announces Reverse Stock Split of Common Stock	09/06/23
Finch Announces Reverse Stock Split of Common Stock	09/06/23
FINCH THERAPEUTICS GROUP, INC. : Change in Directors or Principal Officers (form 8-K)	30/05/23
FINCH THERAPEUTICS GROUP, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	18/05/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Finch Therapeutics Group, Inc.

Azioni

FNCH

US31773D2009

Altre lingue

Filtri